CytomX Therapeutics, Inc.

US$2.19As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CTMXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (15.08%)
Div yield —
ROE (43.55%)
Biotechnology
Beta (5Y) 2.24
PE TTM —
TSR TTM (38.66%)
Mkt cap US$477.4M
ROIC (29.49%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.76
26.23%
(87.31%)
Hold 7|2|3|0|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
2.49%
(2.68%)
4.71%
(0.12%)
Revenue$M
32.57
31.92
33.50
35.43
16.59%
9.08%
10.59%
14.14%
Peers (US$477.4M)
Cap (US$)
PE
483.0M
—
478.7M
30.07x
Capital
TTM
5Y
10Y
Leveragex
3.666
0.336
0.258
EBIT/Intx
6.608
1.299
1.119
Own earn%
294.19
(138.80)
(139.10)
Sh yield%
51.44
42.71
40.06
Owners
Insiders/Inst%
7.62
31.51
Short interest%
3.53
SBC / revenue%
5.30
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
5–13
$1 testx
0.0
Incr. ROIC%
3